Study for the efficacy, safety, and tolerability of different small doses of PEG-4000 (ELS) alone or in combination with lactulose in bowel preparation for pediatrics

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029410

Enrollment

Unknown

Registered

2020-01-30

Start date

2019-01-01

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal diseases

Interventions

A:PEG-4000 (ELS) 40ml/kg

B:PEG-4000 (ELS) 60ml/kg

C:Lactulose+PEG-4000 (ELS) 20ml/kg

D:Lactulose+PEG-4000 (ELS) 30ml/kg

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) The subject guardian is voluntarily enrolled,can understand and sign the informed consent; (2) Participant's age should be between 6 to 18 years old; (3) No serious disease(eg serious liver,kidney,heart insufficiency,etc).

Exclusion criteria

Exclusion criteria: (1) Gastrointestinal obstruction, gastric retention, intestinal perforation, severe active gastrointestinal bleeding, toxic enteritis, toxic megacolitis, galactosemia; (2) Allergy to polyethylene glycol; (3) Allergy to lactulose and its components.

Design outcomes

Primary

Measure	Time frame
Boston bowel preparation sacle;	—

Secondary

Measure	Time frame
Adverse events;Compliance and satisfaction;	—

Countries

China

Contacts

Public ContactLibo Wang

First Hospital of Jilin University

wanglibo75@163.com+86 13604431511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026